Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
grade A 73.08 1.16% 0.84
GKOS closed up 1.16 percent on Monday, March 18, 2019, on 1.33 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GKOS trend table...

Date Alert Name Type % Chg
Mar 15 MACD Bullish Signal Line Cross Bullish 1.16%
Mar 15 180 Bullish Setup Bullish Swing Setup 1.16%
Mar 15 Multiple of Ten Bullish Other 1.16%
Mar 14 Multiple of Ten Bearish Other 5.45%
Mar 13 Multiple of Ten Bullish Other 2.35%
Mar 13 BB Squeeze Ended Range Expansion 2.35%
Mar 13 Up 3 Days in a Row Strength 2.35%
Mar 13 Up 4 Days in a Row Strength 2.35%
Mar 12 Crossed Above 20 DMA Bullish 5.67%
Mar 12 Bollinger Band Squeeze Range Contraction 5.67%

Older signals for GKOS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Medicine Surgery Glaucoma Implant Ophthalmology Drainage Vision Blindness Incision Treatment Of Glaucoma Eye Surgery Pipeline Products Intraocular Pressure
Is GKOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 75.51
52 Week Low 26.75
Average Volume 377,809
200-Day Moving Average 55.7277
50-Day Moving Average 65.2844
20-Day Moving Average 69.165
10-Day Moving Average 68.955
Average True Range 2.6214
ADX 15.35
+DI 33.635
-DI 22.2763
Chandelier Exit (Long, 3 ATRs ) 67.64580000000001
Chandelier Exit (Short, 3 ATRs ) 70.9842
Upper Bollinger Band 73.8398
Lower Bollinger Band 64.4902
Percent B (%b) 0.92
BandWidth 13.51782
MACD Line 1.4177
MACD Signal Line 1.227
MACD Histogram 0.1907
Fundamentals Value
Market Cap 2.51 Billion
Num Shares 34.4 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -1827.00
Price-to-Sales 8.40
Price-to-Book 9.34
PEG Ratio -14.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 77.55
Resistance 3 (R3) 77.25 75.46 76.81
Resistance 2 (R2) 75.46 74.32 75.61 76.56
Resistance 1 (R1) 74.27 73.62 74.87 74.57 76.31
Pivot Point 72.48 72.48 72.78 72.63 72.48
Support 1 (S1) 71.29 71.34 71.89 71.59 69.85
Support 2 (S2) 69.50 70.64 69.65 69.60
Support 3 (S3) 68.31 69.50 69.36
Support 4 (S4) 68.61